A meeting of minds at AstraZeneca Interviewee/Contributor José Baselga Organisation AstraZeneca Plc Cancer (Oncology) Drug discovery Strategy Read more about A meeting of minds at AstraZeneca
Organs-on-chips enter the laboratories of big pharma Interviewee/Contributor Lorna Ewart and Geraldine Hamilton Organisation AstraZeneca Plc and Emulate Inc Drug discovery Strategy Drug resistance Read more about Organs-on-chips enter the laboratories of big pharma
Precision Medicine: The challenge of using big data to help patients Interviewee/Contributor Ruth March Organisation AstraZeneca Plc Academic Research Biomarker Cancer (Oncology) Personalised medicine Read more about Precision Medicine: The challenge of using big data to help patients
Why AstraZeneca is revisiting olaparib Interviewee/Contributor Jane Robertson Organisation AstraZeneca Plc Cancer (Oncology) Clinical trials Read more about Why AstraZeneca is revisiting olaparib
The art of tapping into academic expertise Interviewee/Contributor Jane Buus Laursen Organisation AstraZeneca Technology transfer (office) Academic Research Read more about The art of tapping into academic expertise
Managing Innovation at AstraZeneca Interviewee/Contributor Shaun Grady Organisation AstraZeneca Strategy Read more about Managing Innovation at AstraZeneca
Personalised medicine at AstraZeneca Interviewee/Contributor Ruth March Organisation AstraZeneca Personalised medicine Read more about Personalised medicine at AstraZeneca